EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Host and microbiome lipid metabolism in colorectal cancer development and therapy

Gabriel Medina Evora, Madita Brauer, Elisabeth Letellier

Trends in Cancer · 2025-11 · 11 (11) · 1041-1057

DOI: 10.1016/j.trecan.2025.08.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2025-11. Verfasst von Gabriel Medina Evora und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg. Hauptthemen laut MEDLINE: Lipid Metabolism, Gastrointestinal Microbiome, Colorectal Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Luxembourg, National Research Fund, Fondation Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) remains one of the most prevalent cancers, with treatment largely dependent on surgery and chemotherapy, underscoring the need for novel or adjunct therapies. Cancer cells reprogram their lipid metabolism to support proliferation, invasiveness, and chemoresistance, making it a promising therapeutic target. Although several inhibitors of lipogenesis, lipases, lipid uptake, and lipid storage are under investigation in CRC, none have yet shown sufficient efficacy. Importantly, the tumor microenvironment (TME) and the microbiome influence CRC lipid metabolism by supplying compensatory lipids and engaging in crosstalk that affects the efficacy of lipid-targeting therapies. This review describes the role of lipids in CRC and explores how the TME and the gut/tumor microbiome may contribute to current challenges in the development of effective lipid-targeting therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid MetabolismGastrointestinal MicrobiomeColorectal NeoplasmsHumansTumor MicroenvironmentAdipocytesDrug Resistance, NeoplasmNeoplasm InvasivenessAntineoplastic AgentsAnimalsDysbiosisLipogenesis

Stichwörter der Autor:innen

colorectal cancerdietinhibitorslipid metabolismmicrobiometumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg; Institute for Advanced Studies, University of Luxembourg, Esch-sur-Alzette,…
  • Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg. Electronic address: Elisabeth.Letellier@uni.lu.

Förderung

  • University of Luxembourg
  • National Research Fund
  • Fondation Cancer
  • Fund for Scientific Research

Zitieren

APA

Medina Evora, G., Brauer, M., & Letellier, E. (2025). Host and microbiome lipid metabolism in colorectal cancer development and therapy. Trends in Cancer, 11(11), 1041-1057. https://doi.org/10.1016/j.trecan.2025.08.005

Vancouver

Medina Evora G, Brauer M, Letellier E. Host and microbiome lipid metabolism in colorectal cancer development and therapy. Trends in Cancer. 2025;11(11):1041-1057. doi:10.1016/j.trecan.2025.08.005

BibTeX
@article{MedinaEvora2025,
  author = {Medina Evora, Gabriel and Brauer, Madita and Letellier, Elisabeth},
  title = {Host and microbiome lipid metabolism in colorectal cancer development and therapy},
  journal = {Trends in Cancer},
  year = {2025},
  volume = {11},
  number = {11},
  pages = {1041--1057},
  doi = {10.1016/j.trecan.2025.08.005}
}
Kostenlos starten →